SCHEMBL29929664

SCHEMBL29929664

COc1cc2oc3cc(OC)c(OC)c(CC=C(C)C)c3c(=O)c2c(O)c1CC=C(C)C

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 7/20 0.87
GAA P10253 7/20 0.87
SI P14410 7/20 0.87
MGAM2 Q2M2H8 7/20 0.87
IDH1 O75874 4/20 0.87
FASN P49327 4/20 0.87
SIRT2 Q8IXJ6 3/20 0.87
RELA Q04206 3/20 0.87
NFKB1 P19838 1/20 0.87
PTPN1 P18031 5/20 0.73
PDE4D Q08499 4/20 0.73
SMPD1 P17405 3/20 0.73
CYP19A1 P11511 3/20 0.73
PGAM1 P18669 3/20 0.73
NUDT1 P36639 3/20 0.73
AKR1B1 P15121 2/20 0.73
KDM4E B2RXH2 1/20 0.73
MEN1 O00255 1/20 0.73
KDM1A O60341 1/20 0.73
USP2 O75604 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3740906 1.00 MGAM (0.87) MGAMGAASIMGAM2IDH1
SCHEMBL30830372 0.93 MGAM (0.85) MGAMGAASIMGAM2IDH1
SCHEMBL29929598 0.93 MGAM (1.00) MGAMGAASIMGAM2IDH1
SCHEMBL3742268 0.93 MGAM (1.00) MGAMGAASIMGAM2IDH1
SCHEMBL3750432 0.93 MGAM (0.85) MGAMGAASIMGAM2IDH1
SCHEMBL29974819 0.93 MGAM (1.00) MGAMGAASIMGAM2IDH1
SCHEMBL30830383 0.91 MGAM (0.79) MGAMGAASIMGAM2IDH1
SCHEMBL27311464 0.91 MGAM (0.79) MGAMGAASIMGAM2IDH1
SCHEMBL30830382 0.91 MGAM (0.79) MGAMGAASIMGAM2IDH1
SCHEMBL20620648 0.90 MGAM (0.75) MGAMGAASIMGAM2IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025083495-A1 COMPOSITIONS FOR SEBUM CONTROL Dyson Operations PTE. LTD. (SG) 2025-04-24 WO claimed
US-20240315965-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2024-09-26 US claimed
WO-2022182527-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2022-09-01 WO claimed
CN-122055131-A Composition for sebum control 戴森运营私人有限公司 2026-05-15 CN disclosed
US-12507703-B2 Methods, devices and compositions for preserving human milk THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-12-30 US disclosed
US-20250169516-A1 METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-05-29 US disclosed
WO-2025083495-A1 COMPOSITIONS FOR SEBUM CONTROL Dyson Operations PTE. LTD. (SG) 2025-04-24 WO disclosed
US-12239142-B2 Methods, devices and compositions for preserving human milk THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-03-04 US disclosed
US-20240268402-A1 Methods, Devices and Compositions for Preserving Human Milk THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2024-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12507703-B2 Methods, devices and compositions for preserving human milk LPL, CEL, LPO MGAM 92/4885GAA 446/4885SI 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.